August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Karine Tawagi: Pluvicto FDA Approval for Use Pre-Chemotherapy in Prostate Cancer Based on PSMAfore Trial
Mar 30, 2025, 13:06

Karine Tawagi: Pluvicto FDA Approval for Use Pre-Chemotherapy in Prostate Cancer Based on PSMAfore Trial

Karine Tawagi, Assistant Professor of Clinical Medicine and Fellowship Program Director at the University of Illinois Chicago, shared a post on X:

“Pluvicto FDA approval pre-chemo based on PSMAfore in prostate cancer.

Lu-PSMA-617 versus ARPI switch in taxane-naïve mCRPC patients:

  • Delayed worsening in pain + HRQoL + less AEs
  • rPFS met
  • no OS difference but results are likely confounded by rate of crossover.”

Karine Tawagi